Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
Demonstrate significant bleed reduction in hemophilia A and B
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
Subscribe To Our Newsletter & Stay Updated
